Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

Hippocampus

Volumn 11, Issue 5, 2001, Pages 508-519

  Harrison, Paul J ^a,b   Eastwood, Sharon L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Dendrite; Hippocampus; Morphometry; Psychosis; Synapse; Synaptic protein

Indexed keywords

4 AMINOBUTYRIC ACID; CELL MARKER; GLUTAMIC ACID;

ARTICLE; CELL SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOARCHITECTURE; DEGENERATIVE DISEASE; DENDRITE; GABAERGIC SYSTEM; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; IMAGING; NERVE CELL; NEUROPATHOLOGY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SUBICULUM; SYMPTOMATOLOGY; SYNAPSE;

HIPPOCAMPUS; HUMANS; NEURAL PATHWAYS; SCHIZOPHRENIA; SYNAPSES;

EID: 0035177944     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.1067     Document Type: Article

References (154)

1. Regional zinc staining in postmortem hippocampus from schizophrenic patients
2. Cytoarchitecture of the entorhinal cortex in schizophrenia
3. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects
4. Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection
5. A unitary model of schizophrenia-Bleuler's "fragmented phrene" as schizencephaly
6. The medial temporal lobe in schizophrenia
7. Hippocampal pathology
8. Human fetal hippocampal development. 1. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features
9. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia
10. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia
11. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions
12. Absence of neurodegeneration and neural injury in the cerebral cortex in s sample of elderly patients with schizophrenia
13. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia
14. The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission
15. Emerging principles of altered neural circuitry in schizophrenia
16. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics
17. Reduced neuronal size in posterior hippocampus of schizophrenic patients
18. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood
19. Reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
20. 65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain
21. Expression of synaptophysin in sprouting neurons after entorhinal lesion in the rat
22. Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: Clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia
23. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study
24. The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia
25. Developmental and plasticity-related differential expression of SNAP-25 isoforms in the rat brain
26. Golgi preparations as a tool in neuropathology with particular reference to investigations of the human telencephalic cortex
27. Control of spine formation by electrical activity in the adult rat cerebellum
28. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics
29. Induction of long-term potentiation is associated with major ultrastructural changes of activated synapses
30. A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia
31. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon
32. Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia
33. Increased dendritic MAP2 expression in the hippocampus in schizophrenia
34. Glial cell loss and reduced neuronal size in the anterior cingulate cortex in major depressive disorder
35. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains
36. Decreased hippocampal (CA3) NMDA receptors in schizophrenia
37. Structural correlates of cognition in dementia: Quantification and assessment of synapse change
38. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography
39. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia
40. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections
41. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and unipolar depression: A study of complexin mRNAs
42. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a western blot study of synaptophysin, GAP-43 and the complexins
43. Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study
44. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia
45. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
46. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes
47. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain
48. Synaptophysin gene expression in schizophrenia-investigation of synaptic pathology in the cerebral cortex
49. Cerebellar synaptic protein expression in schizophrenia
50. Dendritic spine changes associated with hippocampal long-term synaptic plasticity
51. Perspectives from other diseases and lesions
52. Cell loss in the hippocampus of schizophrenics
53. Entorhinal cortex pre-alpha cell clusters in schizophrenia: Quantitative evidence of a developmental abnormality
54. Differential expression of synaptosome-associated protein 25kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero
55. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
56. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease
57. Schizophrenia: A disconnection syndrome?
58. The left medial temporal region and schizophrenia. A PET study
59. Structural synaptic modifications associated with hippocampal LTP and behavioral learning
60. Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease
61. Synaptic pathology in Borna disease virus persistent infection
62. The neuropsychology of schizophrenia
63. The subiculum: A potential site of action for novel antipsychotic drugs
64. On the neuropathology of schizophrenia and its dementia: Neurodevelopmental, neurodegenerative, or both?
65. Schizophrenia: A disorder of neurodevelopment?
66. The neuropathology of schizophrenia-a critical review of the data and their interpretation
67. The neuropathological effects of antipsychotic drugs
68. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
69. Methodological issues
70. Hippocampal neuron number in schizophrenia: A stereological study
71. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
72. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia
73. Synapsin I and syntaxin 1B: Key elements in the control of neurotransmitter release are regulated by neuronal activation and long-term potentiation in vivo
74. Correlation of neuronal cell body size in motor cortex and hippocampus with body height, body weight, and axonal length
75. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. I. Superior frontal and inferior temporal cortex
76. Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways
77. Hippocampal synaptic pathology in patients with temporal lobe epilepsy
78. Synaptic pathology
79. Medium-sized neurofilament protein related to maturation of a subset of cortical neurons
80. Synaptic density in human frontal cortex: Developmental changes and effects of ageing
81. Regional differences in synaptogenesis in human cerebral cortex
82. Quantitative study of synaptophysin immunoreactivity of cerebral cortex and spinal cord in motor neuron disease
83. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
84. Hippocampal pathologic findings in schizophrenia. A morphometric study
85. From birth to onset: A developmental perspective of schizophrenia in two national birth cohorts
86. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
87. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex-the Feinberg hypothesis revisited
88. Dendrites are more spiny on mature hippocampal neurons when synapses are inactivated
89. A neurohistological correlate of schizophrenia
90. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia
91. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex
92. Synaptophysin immunoreactivity in temporal lobe epilepsy-associated hippocampal sclerosis
93. Synaptic plasticity and dynamic modulation of the postsynaptic membrane
94. Chronic stress alters synaptic terminal structure in hippocampus
95. Proton magnetic resonance spectroscopy: An in vivo method of estimating hippocampal neuronal depletion in schizophrenia
96. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity
97. Altered synaptic circuitry in the human temporal neocortex removed from epileptic patients
98. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system
99. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease
100. Quantitative immunohistochemistry of synaptophysin in human neocortex: An alternative method to estimate density of presynaptic terminals in paraffin sections
101. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat
102. Quantitative synaptic alterations in the human neocortex during normal aging
103. Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment
104. Early and late environmental risk factors for schizophrenia
105. Schizophrenia as a disorder of developmentally reduced synaptic connectivity
106. Disordered functional connectivity in schizophrenia
107. Synucleins are developmentally expressed, and α-synuclein regulates the size of the pre-synaptic vesicular pool in primary hippocampal neurons
108. Age-changes of brain synapses and synaptic plasticity in response to an enriched environment
109. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging-a meta-analytic study
110. Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconsulsive shock
111. The morphology of synapses
112. Delayed hippocampal damage in humans following cardiorespiratory arrest
113. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex in subjects with schizophrenia
114. Differential regulation of synaptic vesicle protein gene expression by target and synaptic activity
115. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia
116. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy
117. Neuronal and glial somal size in the prefrontal cortex-a postmortem morphometric study of schizophrenia and Huntington disease
118. Synaptic development of the cerebral cortex: Implications for learning, memory, and mental illness
119. Gliosis and its implications for the disease process
120. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders-preliminary findings
121. Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents
122. Hippocampal connectivity and Alzheimer's dementia: Effects of synapse loss and tangle frequency in a two-component model
123. Dementia with Lewy bodies versus pure Alzheimer disease: Differences in cognition, neuropathology, cholinergic dysfunction, and synapse density
124. Increased synapsin 1 immunoreactivity during long-term potentiation in rat hippocampus
125. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
126. Post-mortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2, and MAP1B) in the rat and human hippocampus
127. The reduced neuropil hypothesis: A circuit based model of schizophrenia
128. Circuit-specific alterations in hippocampal synaptophysin in immunoreactivity predict spatial learning impairment in aged rats
129. Abnormal reinnervation as a basis for schizophrenia
130. Lamina-specific synaptic activation causes domain-specific alterations in dendritic immunostaining for MAP2 and CAM kinase II
131. Temporal lobe epilepsy with and without psychosis: Exploration of hippocampal pathology including that in subpopulations of neurons defined by their content of immunoreactive calcium-binding proteins
132. The synaptic vesicle cycle: A cascade of protein-protein interactions
133. Spine loss and other dendritic abnormalities in epilepsy
134. Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses
135. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucost and neocortical alterations with deficit syndrome
136. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
137. 65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain
138. Reduced synaptophysin immunoreactivity in the dentate gyrus of prepulse inhibition-impaired isolation-reared rats
139. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia
140. Hippocampal volume in first-episode psychoses and chronic schizophrenia
141. Schizophrenia: Developmental neuroscience and pathobiology
142. Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia
143. From neuropathology to neurodevelopment
144. Cell biology of the hippocampal formation in schizophrenia
145. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
146. Hippocampal microtubule-associated protein-2 alterations with contextual memory
147. Meta-analysis of regional brain volumes in schizophrenia
148. SNAP-25 deficit and hippocampal connectivity in schizophrenia
149. Asymmetrical hippocampal circuitry and schizophrenia
150. Size, shape, and orientation of neurons in the left and right hippocampus: Investigation of normal asymmetries and alterations in schizophrenia
151. The hippocampus in schizophrenia: Lateralized increase in neuronal density and altered cytoarchitectural asymmetry
152. Synaptic vesicle size and number are regulated by a clathrin adaptor protein required for endocytosis
153. Citron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus